News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,249 Results
Type
Article (40879)
Company Profile (267)
Press Release (680093)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204656)
Career Advice (2022)
Deals (35532)
Drug Delivery (110)
Drug Development (81373)
Employer Resources (173)
FDA (16403)
Job Trends (14942)
News (346355)
Policy (32723)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2565)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49575)
ALS (168)
Alzheimer's disease (1661)
Antibody-drug conjugate (ADC) (306)
Approvals (16669)
Artificial intelligence (505)
Autoimmune disease (148)
Automation (37)
Bankruptcy (361)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (633)
Cancer (4763)
Cardiovascular disease (395)
Career advice (1707)
Career pathing (35)
CAR-T (278)
CDC (44)
Celiac Disease (2)
Cell therapy (732)
Cervical cancer (36)
Clinical research (69505)
Collaboration (1678)
Company closure (4)
Compensation (1148)
Complete response letters (52)
COVID-19 (2707)
CRISPR (87)
C-suite (817)
Cystic fibrosis (143)
Data (6166)
Decentralized trials (2)
Denatured (25)
Depression (131)
Diabetes (497)
Diagnostics (6673)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (246)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (228)
Earnings (90051)
Editorial (55)
Employer branding (21)
Employer resources (152)
Events (117207)
Executive appointments (961)
FDA (19491)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1452)
Gene editing (191)
Generative AI (43)
Gene therapy (587)
GLP-1 (962)
Government (4653)
Grass and pollen (6)
Guidances (383)
Healthcare (18869)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (56)
Indications (104)
Infectious disease (2967)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (242)
Interviews (315)
IPO (16640)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (644)
Lymphoma (374)
Machine learning (42)
Management (59)
Manufacturing (780)
MASH (161)
Medical device (13755)
Medtech (13807)
Mergers & acquisitions (19956)
Metabolic disorders (1254)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (311)
Neuropsychiatric disorders (86)
Neuroscience (2877)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4509)
Now hiring (65)
Obesity (588)
Opinion (257)
Ovarian cancer (165)
Pain (197)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (488)
Patient recruitment (476)
Peanut (55)
People (58824)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21669)
Phase 2 (30590)
Phase 3 (22793)
Pipeline (5139)
Policy (279)
Postmarket research (2564)
Preclinical (9190)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (278)
Rare diseases (821)
Real estate (5954)
Recruiting (70)
Regulatory (24429)
Reports (51)
Research institute (2383)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (189)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3612)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (986)
Venture capital (86)
Weight loss (377)
Women's health (88)
Worklife (18)
Date
Today (109)
Last 7 days (590)
Last 30 days (2105)
Last 365 days (29857)
2026 (2977)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46539)
2018 (35019)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39199)
Australia (6405)
California (11182)
Canada (3257)
China (1089)
Colorado (473)
Connecticut (470)
Delaware (332)
Europe (84447)
Florida (1663)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (853)
India (64)
Indiana (515)
Iowa (22)
Japan (421)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1371)
Massachusetts (8020)
Michigan (320)
Minnesota (622)
Mississippi (5)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2972)
New Mexico (28)
New York (2946)
North Carolina (1439)
North Dakota (8)
Northern California (5452)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2258)
Puerto Rico (23)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4352)
Tennessee (172)
Texas (1726)
United States (39646)
Utah (334)
Vermont (1)
Virginia (258)
Washington D.C. (81)
Washington State (914)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
721,249 Results for "cerecin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Cerecin strengthens position in neurometabolism with addition to pipeline
Cerecin Inc., a clinical-stage biotechnology company pioneering innovative neurotherapeutics, announced the in-license of CER-022 from the University of Alberta.
September 19, 2023
·
5 min read
BioMidwest
Cerecin forges strategic partnership with A*STAR’s Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding with A*STAR’s Institute of Molecular and Cell Biology.
November 30, 2023
·
5 min read
BioMidwest
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023
Cerecin Inc. announced that new data on investigational CER-0001 in infantile spasms has been accepted for presentation at the 35th International Epilepsy Congress, held in Dublin, Ireland from September 2nd-6th 2023.
August 29, 2023
·
6 min read
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.
February 10, 2026
·
2 min read
Press Releases
Repare Announces Completion of Acquisition by XenoTherapeutics, Inc.
January 29, 2026
·
6 min read
Press Releases
Encision Inc. Announces Fiscal 2026 Third Quarter Results
February 4, 2026
·
1 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - February 9, 2026
February 10, 2026
·
1 min read
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
1 of 72,125
Next
